LUCENTIS kit for intravitreal injection 10mg/mL [age-related macular degeneration associated with subfoveal choroidal neovascularization] (ルセンティス硝子体内注射用キット10mg/mL［中心窩下脈絡膜新生血管を伴う加齢黄斑変性症］) Japó - anglès - すりの適正使用協議会 RAD-AR Council, Japan

lucentis kit for intravitreal injection 10mg/ml [age-related macular degeneration associated with subfoveal choroidal neovascularization] (ルセンティス硝子体内注射用キット10mg/ml［中心窩下脈絡膜新生血管を伴う加齢黄斑変性症］)

novartis pharma k.k. - ranibizumab(genetical recombination) - injection

LUCENTIS kit for intravitreal injection 10mg/mL [macular edema following retinal vein occlusion, choroidal neovascularisation in pathologic myopia, diabetic macular edema] (ルセンティス硝子体内注射用キット10mg/mL［網膜静脈閉塞症に伴う黄斑浮腫、病的近視における脈絡膜新生血管、糖尿病黄斑浮腫］) Japó - anglès - すりの適正使用協議会 RAD-AR Council, Japan

lucentis kit for intravitreal injection 10mg/ml [macular edema following retinal vein occlusion, choroidal neovascularisation in pathologic myopia, diabetic macular edema] (ルセンティス硝子体内注射用キット10mg/ml［網膜静脈閉塞症に伴う黄斑浮腫、病的近視における脈絡膜新生血管、糖尿病黄斑浮腫］)

novartis pharma k.k. - ranibizumab(genetical recombination) - injection

LUCENTIS solution for intravitreal injection 10mg/mL [age-related macular degeneration associated with subfoveal choroidal neovascularization] (ルセンティス硝子体内注射液10mg/mL［中心窩下脈絡膜新生血管を伴う加齢黄斑変性症］) Japó - anglès - すりの適正使用協議会 RAD-AR Council, Japan

lucentis solution for intravitreal injection 10mg/ml [age-related macular degeneration associated with subfoveal choroidal neovascularization] (ルセンティス硝子体内注射液10mg/ml［中心窩下脈絡膜新生血管を伴う加齢黄斑変性症］)

novartis pharma k.k. - ranibizumab(genetical recombination) - injection

LUCENTIS solution for intravitreal injection 10mg/mL [macular edema following retinal vein occlusion, choroidal neovascularisation in pathologic myopia, diabetic macular edema] (ルセンティス硝子体内注射液10mg/mL［網膜静脈閉塞症に伴う黄斑浮腫、病的近視における脈絡膜新生血管、糖尿病黄斑浮腫］) Japó - anglès - すりの適正使用協議会 RAD-AR Council, Japan

lucentis solution for intravitreal injection 10mg/ml [macular edema following retinal vein occlusion, choroidal neovascularisation in pathologic myopia, diabetic macular edema] (ルセンティス硝子体内注射液10mg/ml［網膜静脈閉塞症に伴う黄斑浮腫、病的近視における脈絡膜新生血管、糖尿病黄斑浮腫］)

novartis pharma k.k. - ranibizumab(genetical recombination) - injection

LUCENTIS solution for intravitreal injection 10mg/mL [retinopathy of prematurity] (ルセンティス硝子体内注射液10mg/mL［未熟児網膜症］) Japó - anglès - すりの適正使用協議会 RAD-AR Council, Japan

lucentis solution for intravitreal injection 10mg/ml [retinopathy of prematurity] (ルセンティス硝子体内注射液10mg/ml［未熟児網膜症］)

novartis pharma k.k. - ranibizumab(genetical recombination) - injection

EYLEA SOLUTION FOR INJECTION IN PREFILLED SYRINGE 2MG Singapur - anglès - HSA (Health Sciences Authority)

eylea solution for injection in prefilled syringe 2mg

bayer (south east asia) pte ltd - aflibercept - injection, solution - 2.0mg/50mcl - aflibercept 2.0mg/50mcl

EYLEA SOLUTION FOR INJECTION IN VIAL 2MG Singapur - anglès - HSA (Health Sciences Authority)

eylea solution for injection in vial 2mg

bayer (south east asia) pte ltd - aflibercept - injection, solution - 2.0mg/50mcl - aflibercept 2.0mg/50mcl

Eylea 2mg50microlitres solution for injection vials Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

eylea 2mg50microlitres solution for injection vials

bayer plc - aflibercept - solution for injection - 40mg/1ml

Eylea Unió Europea - anglès - EMA (European Medicines Agency)

eylea

bayer ag - aflibercept - wet macular degeneration; macular edema; diabetes complications - ophthalmologicals - eylea is indicated for adults for the treatment of:neovascular (wet) age-related macular degeneration (amd);visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo);visual impairment due to diabetic macular oedema (dme);visual impairment due to myopic choroidal neovascularisation (myopic cnv).

Eylea 40mg/ml solution for injection Armènia - anglès - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

eylea 40mg/ml solution for injection

bayer pharma ag - aflibercept - solution for injection - 40mg/ml